Journal
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Volume 33, Issue 12, Pages 2018-2023Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.33.2018
Keywords
N myristoyltransferase; ribosome; human immunodeficiency virus type 1; Pr55(gag); Nef; V myristoylation
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Ministry of Health, Labour and Welfare of Japan
Ask authors/readers for more resources
N-Myristoyltransferase (NMT) isozymes, i e, NMT1 and NMT2, are essential host factors for the AIDS-causing human immunodeficiency virus type-1 (HIV-1), by which the viral proteins Pr55(gag) and Nef are N-myristovlated N-Myristoylation is important for the membrane targeting of modified proteins Since it is predicted that approximately 0 5% of all proteins in the human genome are N-myristoylated, selective inhibition of closely HIV-1-associated NMT isozymes is thought to be important for the improvement of specificity in the anti-HIV-1 strategy with the inhibition of NMT function NMT isozymes contain two characteristic structures, the N-terminal region and the catalytic region Here, it was shown that the N-terminal region of each NMT isozyme is required for isozyme-specific binding to the ribosome The specific binding of each isozyme to the ribosome was associated with HIV-1 production, in which NMT1 and NMT2 in the ribosome were suggested to be mainly related to Pr55(gag) and Nef, respectively These results indicate that the N-terminal region that mediates binding to the ribosome can become a target for NMT-isozyme-specific inhibition, which could block HIV-1 production
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available